HIV-1 protease folding and the design of drugs which do not create resistance.

Abstract

Human immunodeficiency virus type 1 (HIV-1) protease (PR) plays an essential role in the life cycle of the virus. Consequently, its inhibition can control acquired immunodeficiency syndrome (AIDS). Any pharmacological treatment targeting the active site of the protease is known to generate escape mutants. On the other hand, if a drug targets a site crucial… (More)

Topics

  • Presentations referencing similar topics